New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2012
09:40 EDTJOE, F, DK, ABFS, RVBD, JNPR, ESIO, CLF, ABAX, MSCC, IDIX, DV, ACO, RYLGappers report: Bearish gaps
This is a list of stocks making unusual moves on the open versus the prior day close. Gapping stocks often have excessive movements during the day and in the days thereafter. We use 5% for filter criteria and scanned for stocks that traded above $10 the prior day. GAPPING DOWN: RVBD (19.95%), ESIO (15.62%), IDIX (11.72%), ACO (11.44%), ABFS (11.11%), JNPR (10.77%), MSCC (8.73%), ABAX (8.72%), DV (7.18%), RYL (6.57%), F (6.49%), CLF (5.65%), DK (5.32%), JOE (5.23%).
News For ABAX;ABFS;ACO;CLF;DK;DV;ESIO;F;IDIX;JNPR;JOE;MSCC;RVBD;RYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 13, 2015
17:14 EDTMSCCMicrosemi initiated with a Buy at Topeka
Subscribe for More Information
10:00 EDTDKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:48 EDTDKDelek US downgraded to Neutral from Buy at Goldman
Subscribe for More Information
April 10, 2015
07:53 EDTFFord consolidates Ford Sollers joint venture for financial reporting purposes
Subscribe for More Information
06:13 EDTFGeneral Motors added to Focus List at Citigroup following selloff
Subscribe for More Information
April 9, 2015
16:13 EDTABAXAbaxis management to meet with Sidoti
Meeting to be held in San Diego, California on April 10 hosted by Sidoti.
10:00 EDTCLFOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTCLFOn The Fly: Pre-market Movers
HIGHER: Pier 1 Imports (PIR), up 5.8% after earnings beat estimates, dividend boosted, and shares upgraded at Wedbush... Novogen (NVGN) rose after announcing that Australian studies revealed its experimental drug, Anisina, killed melanoma cells irrespective of their mutational status. Shares of small-cap Novogen rose 35% in pre-market trading following the company's report on the studies... TASER (TASR), up 3.8% after announcing UK order from London for 178 AXON body cameras... United Continental (UAL), up 2.8% after narrowing Q1 PRASM forecast... Walgreens Boots Alliance (WBA), up 2.4% after reporting Q2 results. LOWER: Zynga (ZNGA), down 12% after announcing last night that current CEO Don Mattrick will depart the company and the board and Mark Pincus, Zynga's founder and chairman, will return to the role of CEO... Alcoa (AA), down 2% after reporting Q1 financial results and giving 2015 guidance... Cliffs Natural (CLF), down 4.6% after BMO Capital cut it rating to the equivalent of sell and halved its price target on the stock to $4.
09:22 EDTFLKQ Corp., Ford renew patent license agreement
LKQ Corporation (LKQ) and Ford Global Technologies (F) renewed their design patent license agreement, which was first entered into in April 2009. The license agreement grants to LKQ the exclusive right to distribute aftermarket replicas of Ford automotive parts covered by U.S. design patents. The renewal is on substantially the same terms as the previous agreement except that the term now extends until March 2020.
08:42 EDTCLFVale cut to sell, target halved to $4.50 at BMO Capital
BMO Capital downgraded Vale (VALE) to Underperform, its sell rating equivalent, from Market Perform saying the iron ore oversupply is "not letting up." BMO points out that Vale's free cash flow is highly leveraged to the iron price. It cut its price target for shares in half to $4.50 from $9. BMO also lowered its iron ore forecast prices by 13%-20% for 2015-2018. The firm coupled the downgrade of Vale with a downgrade of Cliffs Natural (CLF) to Underperform.
08:36 EDTCLFCliffs Natural cut to sell, target halved to $4 at BMO Capital
Subscribe for More Information
06:49 EDTRYLPulteGroup, Meritage cut to sell at JPMorgan on profit taking call
JPMorgan downgraded both PulteGroup (PHM) and Meritage Homes (MTH) to Underweight from Neutral saying the homebuilders are vulnerable to a pullback over the next six months following their strong year-to-date performance. Underweight is JPMorgan’s equivalent to a sell rating. The firm recommends taking some profits in the sector ahead the Q1 earnings reports amid what it sees as "overly positive" investor sentiment. It thinks homebuilders are "highly unlikely" to raise their 2015 gross margin guidance on the Q1 earnings calls. JPMorgan keeps a $21 price target on shares of PulteGroup and dropped its target for Meritage Homes to $38 from $43. Its only Overweight rated name in the space is Ryland Group (RYL).
06:39 EDTCLFCliffs Natural downgraded to Underperform from Market Perform at BMO Capital
Subscribe for More Information
April 8, 2015
19:09 EDTFGM pressures Canadian workers to reduce pension benefits, Globe and Mail says
Subscribe for More Information
09:08 EDTCLFCliffs Natural asks permission to put assets in Canada up for sale, CP says
Cliffs Natural Resources subsidiaries, which filed for creditor protection in January, are seeking permission to put the Bloom Lake mine, the Wabush Mine, and related port and rail assets up for sale next month, reported Canadian Press, citing a motion filed by monitor FTI Consulting Canada. Reference Link
07:03 EDTMSCCMicrosemi announces expiration of HSR waiting period for Vitesse acquisition
Subscribe for More Information
07:02 EDTMSCCMicrosemi announces expiration of HSR waiting period for Vitesse tender offer
Subscribe for More Information
April 7, 2015
11:28 EDTCLFStocks with call strike movement; CLF PBR
Cliffs Natural (CLF) October 6 call option implied volatility decreased 2% to 66, Petrobras (PBR) October 8 call option implied volatility decreased 2% to 61 according to IVolatility.
April 6, 2015
15:02 EDTDVDeVry announces new credit agreement with up to $550M potential capacity
Subscribe for More Information
06:07 EDTJNPRSpherix issues update on several matters
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use